Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › TNGX

FARALLON CAPITAL MANAGEMENT, L.L.C. position in TNGX

TANGO THERAPEUTICS INC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 4,550,688 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$113.5M, representing 0.50% of its reported portfolio and ranking #34 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TNGX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)4.55M sh
Reported value held$113.54M
Portfolio Weight0.50%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s TNGX position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in TNGX in Q4 2024 at 4,000,000 shares (US$12.4M). The position peaked in Q2 2026 at 12,277,000 shares, worth US$383.8M. Across 8 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,550,688 shares valued at US$113.5M — a reduction of -7,726,312 shares quarter over quarter.. Notable position changes include a 99% increase in Q2 2025 (shares rose 64% over the following quarter), a 35% increase in Q2 2026 (shares fell 20% over the following quarter), a 63% trim in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 4.00M $12.36M New
Q1 2025 4.61M $6.32M Add
Q2 2025 9.16M $46.88M Add
Q3 2025 10.76M $90.36M Add
Q4 2025 13.06M $115.72M Add
Q1 2026 9.10M $190.32M Reduce
Q2 2026 12.28M $383.78M Add
Q3 2026 4.55M $113.54M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$340.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held TNGX?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed TNGX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in TNGX?

As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 4.55M shares of TNGX (TANGO THERAPEUTICS INC), valued at $113.54M, representing 0.50% of its reported portfolio and ranking #34.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling TNGX?

In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. reduced its position in TNGX. The position peaked in Q2 2026 at 12.28M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include Farallon Capital Management, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.